Clinical Trial Update: Effect of Semaglutide in Patients With Psoriasis and Obesity [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating semaglutide for patients with psoriasis and obesity and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Psoriasis

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: The University of Hong Kong | Conditions: Psoriasis (PsO), Obesity and Overweight | Phase 3 | Status: RECRUITING